NasdaqGM - Delayed Quote USD
Neurogene Inc. (NGNE)
At close: November 4 at 4:00 PM EST
After hours: 7:31 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
Total Assets
222,573.00
109,265.00
101,487.00
Total Liabilities Net Minority Interest
36,549.00
255,004.00
193,362.00
Total Equity Gross Minority Interest
186,024.00
-145,739.00
-91,875.00
Total Capitalization
186,024.00
-145,739.00
-91,875.00
Common Stock Equity
186,024.00
-145,739.00
-91,875.00
Capital Lease Obligations
16,255.00
4,689.00
5,209.00
Net Tangible Assets
186,024.00
-145,739.00
-91,875.00
Working Capital
177,375.00
78,068.00
63,102.00
Invested Capital
186,024.00
-145,739.00
-91,875.00
Tangible Book Value
186,024.00
-145,739.00
-91,875.00
Total Debt
16,255.00
4,689.00
5,209.00
Share Issued
12,823.67
12,823.67
12,823.70
Ordinary Shares Number
12,823.67
12,823.67
12,823.70
12/31/2021 - 3/7/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IRON Disc Medicine, Inc.
58.25
+23.59%
QTTB Q32 Bio Inc.
46.84
-1.24%
TSHA Taysha Gene Therapies, Inc.
1.3400
-12.42%
THRD Third Harmonic Bio, Inc.
12.11
-15.53%
DNTH Dianthus Therapeutics, Inc.
28.28
+0.96%
MLTX MoonLake Immunotherapeutics
46.40
-0.77%
TECX Tectonic Therapeutic, Inc.
41.87
+2.42%
KRRO Korro Bio, Inc.
60.13
+3.39%
PRAX Praxis Precision Medicines, Inc.
70.02
+2.47%
IKNA Ikena Oncology, Inc.
1.7200
0.00%